BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19064272)

  • 1. Inhibition of woodchuck hepatitis virus gene expression in primary hepatocytes by siRNA enhances the cellular gene expression.
    Meng Z; Qiu S; Zhang X; Wu J; Schreiter T; Xu Y; Yang D; Roggendorf M; Schlaak J; Lu M
    Virology; 2009 Feb; 384(1):88-96. PubMed ID: 19064272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
    Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
    J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide-induced innate immune responses in primary hepatocytes downregulates woodchuck hepatitis virus replication via interferon-independent pathways.
    Zhang X; Meng Z; Qiu S; Xu Y; Yang D; Schlaak JF; Roggendorf M; Lu M
    Cell Microbiol; 2009 Nov; 11(11):1624-37. PubMed ID: 19573162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks.
    Bruni R; Conti I; Villano U; Giuseppetti R; Palmieri G; Rapicetta M
    Virology; 2006 Feb; 345(1):258-69. PubMed ID: 16271377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluctuation of the cytokine expression in the liver during the chronic woodchuck hepatitis virus (WHV) infection is not related to viral load.
    Schildgen O; Fiedler M; Dahmen U; Li J; Lohrengel B; Lu M; Roggendorf M
    Immunol Lett; 2006 Jan; 102(1):31-7. PubMed ID: 16046239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring woodchuck hepatitis virus (WHV) deletion mutants in chronically WHV-infected woodchucks.
    Botta A; Lu M; Zhen X; Kemper T; Roggendorf M
    Virology; 2000 Nov; 277(2):226-34. PubMed ID: 11080471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo.
    Fiedler M; Rödicker F; Salucci V; Lu M; Aurisicchio L; Dahmen U; Jun L; Dirsch O; Pützer BM; Palombo F; Roggendorf M
    J Virol; 2004 Sep; 78(18):10111-21. PubMed ID: 15331744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by woodchuck hepatitis virus of class I major histocompatibility complex presentation on hepatocytes is mediated by virus envelope pre-S2 protein and can be reversed by treatment with gamma interferon.
    Wang J; Michalak TI
    J Virol; 2006 Sep; 80(17):8541-53. PubMed ID: 16912304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the X gene promoter of woodchuck hepatitis virus.
    Sugata F; Chen HS; Kaneko S; Purcell RH; Miller RH
    Virology; 1994 Nov; 205(1):314-20. PubMed ID: 7975227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection.
    Coffin CS; Pham TN; Mulrooney PM; Churchill ND; Michalak TI
    Hepatology; 2004 Nov; 40(5):1053-61. PubMed ID: 15382154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes.
    Lu M; Lohrengel B; Hilken G; Kemper T; Roggendorf M
    J Virol; 2002 Jan; 76(1):58-67. PubMed ID: 11739671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of WHV-HDV replication in acute fatal course of woodchuck hepatitis.
    D'Ugo E; Canitano A; Catone S; Argentini C; Giuseppetti R; Orobello S; Palmieri G; Rapicetta M
    Arch Virol; 2008; 153(11):2069-76. PubMed ID: 18985276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro expression of wild type and precore mutant woodchuck hepatitis virus].
    Lu Q; Zhang L; Liang C; Luo K
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):107-9. PubMed ID: 15619810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
    Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
    J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection.
    Menne S; Cote PJ; Butler SD; Toshkov IA; Gerin JL; Tennant BC
    Hepatology; 2007 Mar; 45(3):614-22. PubMed ID: 17326155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatitis C virus replication and expression by small interfering RNA targeting host cellular genes.
    Xue Q; Ding H; Liu M; Zhao P; Gao J; Ren H; Liu Y; Qi ZT
    Arch Virol; 2007; 152(5):955-62. PubMed ID: 17273891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic expression of the woodchuck hepatitis virus X-antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X-antigen antibody response.
    Jacob JR; Ascenzi MA; Roneker CA; Toshkov IA; Cote PJ; Gerin JL; Tennant BC
    Hepatology; 1997 Dec; 26(6):1607-15. PubMed ID: 9398005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of the type I IFN receptor in two woodchuck species and detection of its expression in liver samples from woodchucks infected with woodchuck hepatitis virus (WHV).
    Fan H; Zhu Z; Wang Y; Zhang X; Lu Y; Tao Y; Fan W; Wang Z; Wang H; Roggendorf M; Lu M; Wang B; Yang D
    Cytokine; 2012 Oct; 60(1):179-85. PubMed ID: 22705153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal design and validation of antiviral siRNA for targeting hepatitis B virus.
    Fu J; Tang ZM; Gao X; Zhao F; Zhong H; Wen MR; Sun X; Song HF; Qian XH
    Acta Pharmacol Sin; 2008 Dec; 29(12):1522-8. PubMed ID: 19026173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.